Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | GPR139 | Q6DWJ6 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22828969 | 1.00 | ACP3 (0.53) | ACP3TDP1L3MBTL1ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL22828960 | 0.98 | ACP3 (0.56) | ACP3TDP1L3MBTL1ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL22828987 | 0.98 | ACP3 (0.56) | ACP3TDP1L3MBTL1ALDH1A1LMNA | |
| SCHEMBL5082805 | 0.93 | ACP3 (0.47) | ACP3TDP1L3MBTL1ALDH1A1LMNA | |
| SCHEMBL5076503 | 0.90 | LMNA (0.54) | ACP3TDP1ALDH1A1LMNAKDM4E | |
| Hydrochloric Acid SCHEMBL22828973 | 0.89 | LMNA (0.53) | ACP3TDP1ALDH1A1LMNAKDM4E | |
| SCHEMBL5082686 | 0.85 | KMT2A (0.52) | ACP3TDP1L3MBTL1ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL5082767 | 0.84 | KMT2A (0.51) | ACP3TDP1L3MBTL1ALDH1A1GPR139 | |
| SCHEMBL3823989 | 0.82 | APAF1 (0.55) | ACP3TDP1ALDH1A1LMNAKDM4E | |
| SCHEMBL18722284 | 0.82 | APAF1 (0.55) | ACP3TDP1ALDH1A1LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7408084-B2 | Process for producing optically active β-amino alcohol | KANEKA CORPORATION (JP) | 2008-08-05 | — | — | US | disclosed |
| US-20050277791-A1 | Process for producing optically active beta-amino alcohol | KANEKA CORPORATION (JP) | 2005-12-15 | — | — | US | disclosed |
| EP-1512677-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE s-AMINO ALCOHOL | KANEKA CORPORATION (JP) | 2005-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277791-A1 | Process for producing optically active beta-amino alcohol | ADH1A, ALDH7A1, ADH1C | ACP3 2531/4885TDP1 4161/4885L3MBTL1 3136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.